Mode
Text Size
Log in / Sign up

Graft rejection

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for graft rejection

12 trials tracked for graft rejection: 7 in phase 3 or 4 and 1 with published results. The most-cited published study has 6 citations.

12Trials tracked
7Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 5 Phase 3 2 Phase 2 4 Other / NA 1
  1. Phase 4 Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation Completed · 6 cited
  2. Phase 4 Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation Completed
  3. Phase 4 Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Completed
  4. Phase 4 Azithromycin in Bronchiolitis Obliterans Syndrome Completed
  5. Phase 4 Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients Completed
  6. Phase 3 Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients Completed
Show 6 more trials
  1. Phase 3 Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection Completed
  2. Phase 2 Randomized Trial for Mixed Acute Rejection Completed
  3. Phase 2 Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney Completed
  4. Phase 2 A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection Completed
  5. Phase 2 Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys Completed
  6. N/A HLA-Identical Sibling Renal Transplant Tolerance Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.